Amgen
AMGN
2,501 hedge funds and large institutions have $106B invested in Amgen in 2022 Q4 according to their latest regulatory filings, with 313 funds opening new positions, 847 increasing their positions, 1,006 reducing their positions, and 87 closing their positions.
260% more first-time investments, than exits
New positions opened: 313 | Existing positions closed: 87
16% more funds holding in top 10
Funds holding in top 10: 85 → 99 (+14)
15% more capital invested
Capital invested by funds: $92.5B → $106B (+$13.5B)
8% more funds holding
Funds holding: 2,324 → 2,501 (+177)
2% more call options, than puts
Call options by funds: $1.45B | Put options by funds: $1.42B
0.96% less ownership
Funds ownership: 76.62% → 75.67% (-0.96%)
16% less repeat investments, than reductions
Existing positions increased: 847 | Existing positions reduced: 1,006
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$609M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$484M |
| 3 |
BlackRock
New York
|
+$441M |
| 4 |
Morgan Stanley
New York
|
+$408M |
| 5 |
Renaissance Technologies
New York
|
+$261M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$1.68B |
| 2 |
UBS AM
Chicago,
Illinois
|
-$759M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$503M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$470M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$234M |
AMGN Hedge Fund Activity: Q4 2022 in Review
2,501 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Amgen (AMGN) for Q4 2022, worth a combined $106B — up 15% from $92.5B a quarter earlier.
Buyers outnumbered sellers: 313 funds opened new AMGN positions and 87 closed out — a net gain of 226 holders — while 847 added to existing stakes and 1,006 trimmed.
The largest buyer was JP Morgan Chase, adding an estimated $609M. The largest seller was Goldman Sachs, cutting an estimated $1.68B.
- 2,501 institutional investors held Amgen (AMGN) as of Q4 2022, up from 2,324 in Q3 2022.
- Funds reported $106B of Amgen stock for Q4 2022, up 15% quarter-over-quarter.
- 313 funds opened new Amgen positions in Q4 2022 and 87 closed out, a net change of +226 holders.
- The largest Amgen buyer in Q4 2022 was JP Morgan Chase, an estimated $609M added.
- The largest Amgen seller in Q4 2022 was Goldman Sachs, an estimated $1.68B sold.
Based on aggregated 13F filings for Q4 2022.